HomeCodonis

Codonis

Swiss Premium Provider

for orofacial and myofunctional therapies

Orofacial Myofunctional Disorders

Orofacial and Myofunctional Therapies of CODONIS

Orofacial Myofunctional Disorders (OMDs) are disorders of the muscles and functions of the face and mouth.

Charateristics of CODONIS

Therapeutic Areas

1. LWZ

(Lippen-Wangen-Zungen) Trainer for orofacial muscle training including speech therapy

2. Pteryg

Pain relief and functional therapy for cranio-mandibular dysfunctions

3. Bilabial

Labial force trainer to train the closure of the lips

LWZ1
Pteryg2
Bilabial3

Product Pipeline

Product: LWZ
Launch Preparation

Indication: Orofacial muscle dysfunction

Expected Launch: Q1 2022

Product: Pteryg
Engineering

Indication: Cranio-Mandibular muscle dysfunction

Expected Launch: Q3 2022

Product: Bilabial
Development

Indication: Labial force

Expected Launch: TBD

Product: COD-2021
Research

Indication: Mental Health

Expected Launch: TBD

Product: COD-2022
Ideation

Indication: Tele-Medicine

Expected Launch: TBD

Product: COD-2023
Ideation

Indication: Anti-Infection

Expected Launch: TBD

Product: COD-2024
Ideation

Indication: Myofunctional Therapy

Expected Launch: TBD

Contact us

 

CODONIS AG

Lindenstrasse 27

4123 Allschwil

Switzerland

Our Premium Partners​

CSEM as premium partner of CODONIS
Bernhard Burkard as premium partner of CODONIS
Wild Kuepfer as premium partner of CODONIS
University of Basel as premium partner of CODONIS
Avanti Europe as premium partner of CODONIS

CODONIS

CODONIS is a Swiss based company which develops and markets innovative and forward-looking medical products for logopedics, myofunctional therapy and dentistry.

Get in Touch

Office

Tramstrasse 99, 4132 Muttenz, Switzerland

Email

contact@codonis.com

© 2022 CODONIS AG. All Rights Reserved.